Cited by 2,061SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Open access

Raj, V. Stalin, Mou, Huihui, Smits, Saskia L., Dekkers, Dick H. W., Müller, Marcel A., Dijkman, Ronald, Muth, Doreen, Demmers, Jeroen A. A., Zaki, Ali, Fouchier, Ron A. M., Thiel, Volker, Drosten, Christian, Rottier, Peter J. M., Osterhaus, Albert D. M. E., Bosch, Berend Jan, Haagmans, Bart L.·2013·Nature

DOI 10.1038/nature12005PMC PMC7095326

Open this paper in CoChat — free account Open PDF

Abstract

Most human coronaviruses cause mild upper respiratory tract disease but may be associated with more severe pulmonary disease in immunocompromised individuals. However, SARS coronavirus caused severe lower respiratory disease with nearly 10% mortality and evidence of systemic spread. Recently, another coronavirus (human coronavirus-Erasmus Medical Center (hCoV-EMC)) was identified in patients with severe and sometimes lethal lower respiratory tract infection. Viral genome analysis revealed close relatedness to coronaviruses found in bats. Here we identify dipeptidyl peptidase 4 (DPP4; also known as CD26) as a functional receptor for hCoV-EMC. DPP4 specifically co-purified with the receptor-binding S1 domain of the hCoV-EMC spike protein from lysates of susceptible Huh-7 cells. Antibodies directed against DPP4 inhibited hCoV-EMC infection of primary human bronchial epithelial cells and Huh-7 cells. Expression of human and bat (Pipistrellus pipistrellus) DPP4 in non-susceptible COS-7 cells enabled infection by hCoV-EMC. The use of the evolutionarily conserved DPP4 protein from different species as a functional receptor provides clues about the host range potential of hCoV-EMC. In addition, it will contribute critically to our understanding of the pathogenesis and epidemiology of this emerging human coronavirus, and may facilitate the development of intervention strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature12005

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Self-citation
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Severe acute respiratory syndrome
Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,157
Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Human aminopeptidase N is a receptor for human coronavirus 229E
Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., & Holmes, K. V. (1992) · Nature · doi:10.1038/357420a0 · Cited by 941

Flagged first, then by citations

Show all 25 references

Sorted by citations

Items 301–400 of 1,000

Virus recognition of glycan receptors
Thompson, A. J., de Vries, R. P., & Paulson, J. C. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.01.004 · Cited by 138
Broad Cross-Species Infection of Cultured Cells by Bat HKU2-Related Swine Acute Diarrhea Syndrome Coronavirus and Identification of Its Replication in Murine Dendritic Cells In Vivo Highlight Its Potential for Diverse Interspecies Transmission
Yang, Y., Qin, P., Wang, B., Liu, Y., Xu, G.-H., Peng, L., Zhou, J., Zhu, S., & Huang, Y. (2019) · Journal of Virology · doi:10.1128/jvi.01448-19 · Cited by 140
Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types
Ou, X., O’Leary, H. A., & Broxmeyer, H. E. (2013) · Blood · doi:10.1182/blood-2013-02-487470 · Cited by 136
Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels
Widagdo, W., Raj, V. S., Schipper, D., Kolijn, K., van Leenders, G. J. L. H., Bosch, B., Bensaïd, A., Segalés, J., Baumgärtner, W., Osterhaus, A. D. M. E., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02994-15 · Cited by 136
Self-citation
Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus
Chen, Y.-Q., Rajashankar, K. R., Yang, Y., Agnihothram, S., Liu, C., Lin, Y.-L., Baric, R. S., & Li, F. (2013) · Journal of Virology · doi:10.1128/jvi.01756-13 · Cited by 137
The emergence of the Middle East Respiratory Syndrome coronavirus
Milne-Price, S., Miazgowicz, K. L., & Munster, V. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12166 · Cited by 134
Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus–Host Interactions
Zhang, Y., Chen, Y., Zhou, J. Z., Wang, X., Ma, L., Li, J., Yang, L., Yuan, H., Pang, D., & Ouyang, H. (2022) · Viruses · doi:10.3390/v14112434 · Cited by 137
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats
Ng, M., Ndungo, E., Kaczmarek, M. E., Herbert, A. S., Binger, T., Kuehne, A. I., Jangra, R. K., Hawkins, J. A., Gifford, R. J., Biswas, R., et al. (2015) · eLife · doi:10.7554/elife.11785 · Cited by 139
Self-citation
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design
Ma, C., Wang, L., Tao, X., Zhang, N., Yang, Y., Tseng, C.-T. K., Li, F., Zhou, Y., Jiang, S., & Du, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.086 · Cited by 131
MERS-CoV spike protein: Targets for vaccines and therapeutics
Wang, Q., Wong, G., Lu, G., Yan, J., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.07.015 · Cited by 131
Expression of the COVID‐19 receptor ACE2 in the human conjunctiva
Lange, C., Wolf, J., Auw‐Haedrich, C., Schlecht, A., Boneva, S., Lapp, T., Horres, R., Agostini, H. T., Martin, G., Reinhard, T., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25981 · Cited by 132
Swine enteric alphacoronavirus (swine acute diarrhea syndrome coronavirus): An update three years after its discovery
Yang, Y., Yu, J.-Q., & Huang, Y. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198024 · Cited by 132
Infectivity of human coronavirus in the brain
Cheng, Q., Yang, Y., & Gao, J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102799 · Cited by 132
Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response
Vishnubalaji, R., Shaath, H., & Alajez, N. M. (2020) · Genes · doi:10.3390/genes11070760 · Cited by 130
Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
Ganesh, B., Rajakumar, T., Mathiyazhakan, M., Natesan, M., Jaganathasamy, N., Aridoss, S., Arumugam, E., & Malik, Y. S. (2021) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2020.100694 · Cited by 133
Early events during human coronavirus OC43 entry to the cell
Owczarek, K., Szczepański, A., Milewska, A., Baster, Z., Rajfur, Z., Sarna, M., & Pyrć, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-25640-0 · Cited by 136
Molecular diversity of coronavirus host cell entry receptors
Millet, J. K., Jaimes, J. A., & Whittaker, G. R. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa057 · Cited by 137
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
Zhang, N., Channappanavar, R., Ma, C., Wang, L., Tang, J., Garron, T. M., Tao, X., Tasneem, S., Lu, L., Tseng, C.-T. K., et al. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.03 · Cited by 128
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
Mohapatra, R. K., Pintilie, L., Kandi, V., Sarangi, A. K., Das, D., Sahu, R., & Perekhoda, L. O. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13761 · Cited by 132
Quantitative structure‐activity relationship and molecular docking revealed a potency of anti‐hepatitis C virus drugs against human corona viruses
Elfiky, A. A., Mahdy, S. M., & Elshemey, W. M. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24736 · Cited by 128
Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
Cao, W., Dong, C., Kim, S., Hou, D., Tai, W., Du, L., Im, W., & Zhang, X. H. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.007 · Cited by 128
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control
Durai, P., Batool, M., Shah, M., & Choi, S. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.76 · Cited by 129
Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus
Coleman, C. M., Matthews, K. L., Goicochea, L., & Frieman, M. B. (2013) · Journal of General Virology · doi:10.1099/vir.0.060640-0 · Cited by 126
Prospects for a MERS-CoV spike vaccine
Zhou, Y., Jiang, S., & Du, L. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1506702 · Cited by 126
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic
Gulati, A., Pomeranz, C. L., Qamar, Z., Thomas, S., Frisch, D., George, G., Summer, R. S., DeSimone, J., & Sundaram, B. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.05.006 · Cited by 127
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
Sallenave, J., & Guillot, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01229 · Cited by 126
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
Xia, S., Liu, Q., Wang, Q., Sun, Z., Su, S., Du, L., Ying, T., Lu, L., & Jiang, S. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.007 · Cited by 124
Adaptive Evolution of MERS-CoV to Species Variation in DPP4
Letko, M. C., Miazgowicz, K. L., McMinn, R. J., Seifert, S. N., Sola, I., Enjuanes, L., Carmody, A., van Doremalen, N., & Munster, V. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.045 · Cited by 124
High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus
Scheuplein, V., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara‐Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 123
MERS coronavirus outbreak: Implications for emerging viral infections
Al‐Omari, A., Rabaan, A. A., Salih, S., Al‐Tawfiq, J. A., & Memish, Z. A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.011 · Cited by 123
Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis
Zyoud, S. H. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1600-5 · Cited by 122
A Comprehensive Review About SARS-CoV-2
Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K. (2020) · Future Virology · doi:10.2217/fvl-2020-0124 · Cited by 121
ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host Cells
Tait‐Burkard, C., Verheije, M. H., Haagmans, B. L., van Kuppeveld, F. J. M., Rottier, P. J. M., Bosch, B., & de Haan, C. A. M. (2015) · Journal of Virology · doi:10.1128/jvi.03274-14 · Cited by 121
Self-citation
NAADP-dependent Ca2+ signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system
Gunaratne, G. S., Yang, Y., Li, F., Walseth, T. F., & Marchant, J. S. (2018) · Cell Calcium · doi:10.1016/j.ceca.2018.08.003 · Cited by 121
Statins: Could an old friend help in the fight against COVID‐19?
Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Márquez‐Expósito, L., Rayego‐Mateos, S., Santos‐Sanchez, L., Marchant, V. A., Tejedor-Santamaria, L., Ramos, A. M., Ortíz, A., Egido, J., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15166 · Cited by 121
The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors
Pišlar, A. H., Mitrović, A., Sabotič, J., Fonović, U. P., Nanut, M. P., Jakoš, T., Senjor, E., & Kos, J. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009013 · Cited by 124
Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses
Adedeji, A. O., Singh, K., Kassim, A., Coleman, C. M., Elliott, R., Weiss, S. R., Frieman, M. B., & Sarafianos, S. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02994-14 · Cited by 120
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
Du, L., Tai, W., Yang, Y., Zhao, G., Zhu, Q., Sun, S., Liu, C., Tao, X., Tseng, C.-T. K., Perlman, S. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13473 · Cited by 124
TNF ‐α/ IFN ‐γ synergy amplifies senescence‐associated inflammation and SARS‐CoV ‐2 receptor expression via hyper‐activated JAK / STAT1
Kandhaya‐Pillai, R., Yang, X., Tchkonia, T., Martin, G. M., Kirkland, J. L., & Oshima, J. (2022) · Aging Cell · doi:10.1111/acel.13646 · Cited by 119
Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection
Barlan, A., Zhao, J., Sarkar, M. K., Li, K., McCray, P. B., Perlman, S. M., & Gallagher, T. (2014) · Journal of Virology · doi:10.1128/jvi.00161-14 · Cited by 118
In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection
Eckerle, I., Müller, M. A., Kallies, S., Gotthardt, D. N., & Drosten, C. (2013) · Virology Journal · doi:10.1186/1743-422x-10-359 · Cited by 118
Self-citation
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus–Host Interaction
Kim, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124549 · Cited by 124
Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication
Nakagawa, K., Narayanan, K., Wada, M., & Makino, S. (2018) · Journal of Virology · doi:10.1128/jvi.00902-18 · Cited by 117
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Zhou, Y., Yang, Y., Huang, J., Jiang, S., & Du, L. (2019) · Viruses · doi:10.3390/v11010060 · Cited by 120
Immunosuppressive Drugs and COVID-19: A Review
Schoot, T. S., Kerckhoffs, A. P. M., Hilbrands, L. B., & van Marum, R. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01333 · Cited by 118
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Malczyk, A. H., Kupke, A., Prüfer, S., Scheuplein, V., Hutzler, S., Kreuz, D., Beißert, T., Bauer, S., Hubich-Rau, S., Tondera, C., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01815-15 · Cited by 118
Identification of the Fusion Peptide-Containing Region in Betacoronavirus Spike Glycoproteins
Ou, X., Zheng, W., Shan, Y., Mu, Z., Dominguez, S. R., Holmes, K. V., & Qian, Z. (2016) · Journal of Virology · doi:10.1128/jvi.00015-16 · Cited by 116
Molecular biology of coronaviruses: current knowledge
Artika, I. M., Dewantari, A. K., & Wiyatno, A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04743 · Cited by 122
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
Saha, R. P., Sharma, A. R., Singh, M. K., Samanta, S., Bhakta, S., Mandal, S., Bhattacharya, M., Lee, S. S., & Chakraborty, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01258 · Cited by 118
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
Widjaja, I., Wang, C., van Haperen, R., Gutiérrez-Álvarez, J., van Dieren, B., Okba, N. M. A., Raj, V. S., Li, W., Fernandez-Delgado, R., Grosveld, F., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1597644 · Cited by 115
Self-citation
The avian coronavirus spike protein
Wickramasinghe, I. N. A., van Beurden, S. J., Weerts, E. A. W. S., & Verheije, M. H. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.009 · Cited by 115
Recent applications and strategies in nanotechnology for lung diseases
Zhong, W., Zhang, X., Zeng, Y., Lin, D., & Wu, J. (2021) · Nano Research · doi:10.1007/s12274-020-3180-3 · Cited by 116
Structures of a deltacoronavirus spike protein bound to porcine and human receptors
Ji, W., Peng, Q., Fang, X., Li, Z., Li, Y., Xu, C., Zhao, S., Li, J., Chen, R., Mo, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29062-5 · Cited by 118
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
Luke, T. C., Wu, H., Zhao, J., Channappanavar, R., Coleman, C. M., Jiao, J., Matsushita, H., Liu, Y., Postnikova, E. N., Ork, B. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1061 · Cited by 113
An overview of coronaviruses including the SARS-2 coronavirus – Molecular biology, epidemiology and clinical implications
Kaul, D. (2020) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2020.04.001 · Cited by 115
Middle East Respiratory Syndrome
Shalhoub, S., Memish, Z. A., & Arabi, Y. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-54841-0.00004-4 · Cited by 113
Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor
Pan, B., Fang, S., Zhang, J., Pan, Y., Liu, H., Wang, Y., Li, M., & Liu, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.010 · Cited by 116
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector‐based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Guo, X., Deng, Y. L., Chen, H., Lan, J., Wang, W., Zou, X., Hung, T., Lu, Z., & Tan, W. (2015) · Immunology · doi:10.1111/imm.12462 · Cited by 112
COVID-19, MERS and SARS with Concomitant Liver Injury—Systematic Review of the Existing Literature
Kukla, M., Skonieczna‐Żydecka, K., Kotfis, K., Maciejewska, D., Łoniewski, I., Lara, L. F., Pazgan−Simon, M., Stachowska, E., Kaczmarczyk, M., Koulaouzidis, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051420 · Cited by 115
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV
Milewska, A., Chi, Y., Szczepański, A., Barreto-Durán, E., Dąbrowska, A., Botwina, P., Obłoza, M., Liu, K., Liu, D., Guo, X., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01622-20 · Cited by 112
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
Ying, T., Prabakaran, P., Du, L., Shi, W., Feng, Y., Wang, Y., Wang, L., Li, W., Jiang, S., Dimitrov, D. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9223 · Cited by 110
A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
Tai, W., Zhao, G., Sun, S., Guo, Y., Wang, Y., Tao, X., Tseng, C.-T. K., Li, F., Jiang, S., Du, L., et al. (2016) · Virology · doi:10.1016/j.virol.2016.10.005 · Cited by 110
Ca 2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity
Straus, M. R., Tang, T., Lai, A. L., Flegel, A., Bidon, M. K., Freed, J. H., Daniel, S., & Whittaker, G. R. (2020) · Journal of Virology · doi:10.1128/jvi.00426-20 · Cited by 110
Receptor-binding loops in alphacoronavirus adaptation and evolution
Wong, A. H. M., Tomlinson, A. C. A., Zhou, D., Satkunarajah, M., Chen, K., Sharon, C., Desforges, M., Talbot, P. J., & Rini, J. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01706-x · Cited by 110
Bidirectional association between COVID-19 and the environment: A systematic review
Rahimi, N. R., Fouladi-Fard, R., Aali, R., Shahryari, A., Rezaali, M., Ghafouri, Y., Ghalhari, M. R., Asadi‐Ghalhari, M., Farzinnia, B., Conti, G. O., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110692 · Cited by 109
Binding of the SARS-CoV-2 spike protein to glycans
Hao, W., Ma, B., Li, Z., Wang, X., Gao, X., Li, Y., Qin, B., Shang, S., Cui, S., & Tan, Z. (2021) · 中国科学通报：英文版 · doi:10.1016/j.scib.2021.01.010 · Cited by 111
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus
Vergara‐Alert, J., van den Brand, J. M. A., Widagdo, W., Muñoz, M., Raj, V. S., Schipper, D., Solanes, D., Cordón, I., Bensaïd, A., Haagmans, B. L., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2302.161239 · Cited by 108
Self-citation
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): A Perpetual Challenge
Hajjar, S. A., Memish, Z. A., & McIntosh, K. (2013) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2013.427 · Cited by 108
A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
Beumer, J., Geurts, M. H., Lamers, M. M., Puschhof, J., Zhang, J., van der Vaart, J., Mykytyn, A. Z., Breugem, T. I., Riesebosch, S., Schipper, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25729-7 · Cited by 113
Self-citation
Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding
Lau, S. K. P., Zhang, L., Luk, H. K. H., Xiong, L., Peng, X., Li, K. S. M., He, X., Zhao, S., Fan, R. Y. Y., Wong, A. C. P., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy018 · Cited by 106
Diabetes and COVID-19: The past, the present, and the future
Pranata, R., Henrina, J., Raffaello, W. M., Lawrensia, S., & Huang, I. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154814 · Cited by 109
Emerging Human Middle East Respiratory Syndrome Coronavirus Causes Widespread Infection and Alveolar Damage in Human Lungs
Hocke, A. C., Becher, A., Knepper, J., Peter, A., Holland, G., Tönnies, M., Bauer, T. T., Schneider, P., Neudecker, J., Muth, D., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201305-0954le · Cited by 105
Self-citation
Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry
Li, W., Luo, R., He, Q., van Kuppeveld, F. J. M., Rottier, P. J. M., & Bosch, B. (2017) · Virus Research · doi:10.1016/j.virusres.2017.03.018 · Cited by 107
Self-citation
DPP4 inhibition: Preventing SARS‐CoV ‐2 infection and/or progression of COVID ‐19?
Strollo, R., & Pozzilli, P. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3330 · Cited by 105
Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options
Zumla, A. I., Memish, Z. A., Maeurer, M. J., Bates, M., Mwaba, P., Al‐Tawfiq, J. A., Denning, D. W., Hayden, F. G., & Hui, D. S. C. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70828-x · Cited by 104
Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
Mahmud, S., Rafi, M. O., Paul, G. K., Promi, M. M., Shimu, M. S. S., Biswas, S., Emran, T. B., Dhama, K., Alyami, S. A., Moni, M. A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92176-1 · Cited by 104
Animal models for COVID-19: advances, gaps and perspectives
Fan, C., Wu, Y., Xiong, R., Yang, Y., Ling, C., Liu, S., Liu, S., & Wang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01087-8 · Cited by 110
A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment
Kumar, M., Taki, K., Gahlot, R., Sharma, A., & Dhangar, K. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.139278 · Cited by 103
LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2
Zhao, X., Zheng, S., Chen, D., Zheng, M., Li, X., Li, G., Lin, H., Chang, J., Zeng, H., & Guo, J. (2020) · Journal of Virology · doi:10.1128/jvi.00562-20 · Cited by 107
Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
Robb, C. T., Goepp, M., Rossi, A. G., & Yao, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15206 · Cited by 104
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Zhang, Y.-Y., Li, B.-R., & Ning, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02033 · Cited by 103
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19
Faheem, F., Kumar, B. K., Sekhar, K. V. G. C., Kunjiappan, S., Jamalis, J., Balaña‐Fouce, R., Tekwani, B. L., & Murugesan, S. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104269 · Cited by 103
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
Mudgal, R. K., Nehul, S., & Tomar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1805992 · Cited by 103
CD26/dipeptidylpeptidase IV—chemokine interactions: double-edged regulation of inflammation and tumor biology
Mortier, A., Gouwy, M., Damme, J. V., Proost, P., & Struyf, S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0915-401r · Cited by 103
Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
Channappanavar, R., Lu, L., Xia, S., Du, L., Meyerholz, D. K., Perlman, S. M., & Jiang, S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv325 · Cited by 102
Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
Kim, Y. S., Son, A., Kim, J., Kwon, S. B., Kim, M. H., Kim, P., Kim, J., Byun, Y. H., Sung, J., Lee, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01093 · Cited by 102
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
Kim, M. K., Jeon, J., Kim, S.-W., Moon, J. S., Cho, N. H., Han, E., You, J. H., Lee, J. Y., Hyun, M., Park, J. S., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0146 · Cited by 102
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Liu, X., Huuskonen, S., Laitinen, T., Redchuk, T. A., Bogacheva, M. S., Salokas, K., Pöhner, I., Öhman, T., Tonduru, A. K., Hassinen, A., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110396 · Cited by 104
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
Behl, T., Kaur, I., Aleya, L., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., & BUNGAU, S. G. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.152072 · Cited by 105
Vaccines for the prevention against the threat of MERS-CoV
Du, L., Tai, W., Zhou, Y., & Jiang, S. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1167603 · Cited by 101
Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_4 · Cited by 104
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
Zhao, G., He, L., Sun, S., Qiu, H., Tai, W., Chen, J., Li, J., Chen, Y., Guo, Y., Wang, Y., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00837-18 · Cited by 103
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor
Chen, J., Zhang, W., Li, Y., Liu, C., Dong, T., Chen, H., Wu, C., Su, J., Li, B., Zhang, W., et al. (2025) · Cell · doi:10.1016/j.cell.2025.01.042 · Cited by 106
Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection
Qing, E., Hantak, M. P., Perlman, S. M., & Gallagher, T. (2020) · mBio · doi:10.1128/mbio.02764-19 · Cited by 100
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
Artese, A., Svicher, V., Costa, G., Salpini, R., Maio, V. C. D., Alkhatib, M., Ambrosio, F. A., Santoro, M. M., Assaraf, Y. G., Alcaro, S., et al. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100721 · Cited by 103
Coronaviruses and the human airway: a universal system for virus-host interaction studies
Jónsdóttir, H. R., & Dijkman, R. (2016) · Virology Journal · doi:10.1186/s12985-016-0479-5 · Cited by 99
Self-citation
A review of treatment modalities for Middle East Respiratory Syndrome
Mo, Y., & Fisher, D. A. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw338 · Cited by 99
Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections
Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00569 · Cited by 99
MERS-CoV as an emerging respiratory illness: A review of prevention methods
Baharoon, S. A., & Memish, Z. A. (2019) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2019.101520 · Cited by 99
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
Kleine‐Weber, H., Schroeder, S., Krüger, N., Prokscha, A., Naim, H. Y., Müller, M. A., Drosten, C., Pöhlmann, S., & Hoffmann, M. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1713705 · Cited by 101
Self-citation

Authors: Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., Thiel, V., Drosten, C., Rottier, P. J. M., Osterhaus, A. D. M. E., Bosch, B. J., & Haagmans, B. L.
Affiliations: Erasmus MC (NL)
Utrecht University (NL)
University of Bonn (DE)
Kantonsspital St. Gallen (CH)
Soliman Fakeeh Hospital (SA)
University of Zurich (CH)
Corresponding author: Bosch, Berend Jan
Haagmans, Bart L.
ORCID: Raj, V. Stalin
Mou, Huihui
Dekkers, Dick H. W.
Müller, Marcel A.
Dijkman, Ronald
Muth, Doreen
Demmers, Jeroen A. A.
Zaki, Ali
Fouchier, Ron A. M.
Thiel, Volker
Drosten, Christian
Osterhaus, Albert D. M. E.
Bosch, Berend Jan
Haagmans, Bart L.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2013-03
Volume: 495
Issue: 7440
Pages: 251-254
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature12005
PMC: PMC7095326
OpenAlex: W2119111857
Cited by: 2,061
References: 25
Citations by year: 2026: 41 · 2025: 64 · 2024: 97 · 2023: 130 · 2022: 199 · 2021: 358 · 2020: 609 · 2019: 74 · 2018: 59 · 2017: 61 · 2016: 93 · 2015: 101 · 2014: 86 · 2013: 87
FWCI: 89.49
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders: National Science Foundation
European Commission (223498, 278976)
Deutsche Forschungsgemeinschaft (DR 772/3-1, KA1241/18-1, 772/3)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (132898)
Bundesministerium für Bildung und Forschung
China Scholarship Council
Stiftung Forschung 3R (128-11)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: MERS-CoV, dipeptidyl peptidase IV, CD26, viral receptor, host range, lower respiratory tract infection, SARS-CoV, receptor binding domain, Huh7 cells, bronchial epithelial cells
MeSH terms: Animals, Chlorocebus aethiops, Chiroptera, Epithelial Cells, Humans, Molecular Sequence Data, Receptors, Virus, Coronavirus, Coronavirus Infections, Dipeptidyl Peptidase 4, COS Cells, Bronchioles, Host Specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks